ASR Vermogensbeheer’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$78M Buy
294,441
+6,208
+2% +$1.64M 0.78% 19
2026
Q2
$73.2M Sell
288,233
-424
-0.1% -$98.8K 0.75% 22
2026
Q1
$70.6M Buy
288,657
+5,502
+2% +$1.28M 0.83% 19
2025
Q4
$58.6M Buy
283,155
+43,032
+18% +$8.51M 0.68% 25
2025
Q3
$44.5M Sell
240,123
-746
-0.3% -$128K 0.54% 33
2025
Q2
$36.8M Buy
240,869
+12,009
+5% +$1.85M 0.48% 42
2025
Q1
$38M Buy
+228,860
New +$35.8M 0.56% 35

Other funds holding JNJ

ASR Vermogensbeheer's JNJ Position: Q3 2026 in Review

ASR Vermogensbeheer increased its Johnson & Johnson (JNJ) stake by 2.2% in Q3 2026, buying an estimated $1.64M and bringing the position to 294,441 shares worth $78M. The position accounts for 0.78% of the portfolio, ranked #19.

ASR Vermogensbeheer first reported a position in JNJ in Q1 2025 and has held it in 7 quarters since. 4,739 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • ASR Vermogensbeheer held 294,441 shares of Johnson & Johnson worth $78M as of Q3 2026.
  • ASR Vermogensbeheer bought 6,208 Johnson & Johnson shares in Q3 2026, an estimated $1.64M.
  • Johnson & Johnson made up 0.78% of ASR Vermogensbeheer's portfolio in Q3 2026, its #19 holding.
  • ASR Vermogensbeheer first reported a position in Johnson & Johnson in Q1 2025 and has held it in 7 quarters since.
  • 4,739 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on ASR Vermogensbeheer's 13F filing for Q3 2026, filed 16 Oct 2026.